Norris Cotton Cancer Center

PathfinderHealth Selects Equality Health to Advance Access to Quality Healthcare for Northern Arizona Communities

Retrieved on: 
Tuesday, November 29, 2022

FLAGSTAFF, Ariz., Nov. 29, 2022 /PRNewswire/ -- PathfinderHealth, an affiliate of Northern Arizona Healthcare (NAH), today announced a partnership with Equality Health, a leading provider of value-based physician networks uniquely equipped to address the needs of diverse and historically underserved populations. Effective Jan. 1, 2023, the partnership will bring improved patient and provider services to PathfinderHealth primary care practices in northern Arizona, and help PathfinderHealth, a Clinically Integrated Network and Accountable Care Organization, navigate the transformation to value-based health care initiatives.

Key Points: 
  • Equality Health also will provide PathfinderHealth with new resources to manage the total cost of care through a localized whole-person, cultural care model.
  • Equality Health's unique cultural care model and the companies' shared mission of providing quality care to underserved communities, forged the relationship.
  • A nonprofit health care system, NAH is inclusive of Flagstaff Medical Center, Verde Valley Medical Center, Verde Valley Medical Center Sedona Campus, Northern Arizona Healthcare Camp Verde Campus, Northern Arizona Healthcare Village of Oak Creek, Northern Arizona Healthcare Medical Group, the Cancer Centers of Northern Arizona Healthcare, Northern Arizona Healthcare Orthopedic Surgery Center, EntireCare Rehab & Sports Medicine, Weight Management Clinic, Northern Arizona Healthcare Medical Group Cardiology, Guardian Air and Guardian Medical Transport.
  • "Like" NAH on Facebook by searching Northern Arizona Healthcare Flagstaff and Northern Arizona Healthcare Verde Valley.

Citadel Credit Union Helps Raise Over $2 Million for Cancer Center at Children's Hospital of Philadelphia

Retrieved on: 
Tuesday, October 4, 2022

EXTON, Pa., Oct. 3, 2022 /PRNewswire/ -- Citadel Credit Union, the presenting sponsor of the CHOP Parkway Run & Walk, has announced an additional contribution for CHOP's Cancer Center. Presented to CHOP at the 20th annual Parkway event, Citadel doubled its annual total to $300,000 to help CHOP raise a record-breaking $2 million to fund critical childhood cancer research and care. Citadel, a not-for-profit credit union, has been the presenting sponsor of Parkway since 2019 and has raised a total of $750,000 – and will continue to be the presenting sponsor in 2023.

Key Points: 
  • EXTON, Pa., Oct. 3, 2022 /PRNewswire/ -- Citadel Credit Union, the presenting sponsor of the CHOP Parkway Run & Walk, has announced an additional contribution for CHOP's Cancer Center.
  • In addition to the event on the Parkway, Citadel hosted several of CHOP's Cancer Center Ambassadors at its corporate offices in August.
  • Citadel Credit Union is a not-for-profit, member-owned financial institution that provides banking, investments, and insurance services to more than 240,000 members.
  • Citadel is recognized as a Forbes 2022 Best-in-State Credit Union and a certified 2022 Great Place to Work.

American Cancer Society and Professional Oncology Community Team Up to Provide International Support for Ukrainian Cancer Patients

Retrieved on: 
Monday, March 7, 2022

In response, the American Cancer Society (ACS), in partnership with the American Society of Clinical Oncology (ASCO) and the Sidney Kimmel Cancer Center-Jefferson Health, is taking steps to support all Ukrainian cancer patients and their families, including migrant and multicultural communities.

Key Points: 
  • In response, the American Cancer Society (ACS), in partnership with the American Society of Clinical Oncology (ASCO) and the Sidney Kimmel Cancer Center-Jefferson Health, is taking steps to support all Ukrainian cancer patients and their families, including migrant and multicultural communities.
  • "Disruptions to cancer treatment pose a grave risk to the survival of Ukrainian patients with cancer," said Dr. Karen Knudsen, CEO of the American Cancer Society.
  • "We, along with our invaluable partners, are committed to leveraging our expertise and vast network to help Ukrainian cancer patients and their families, as well as the Ukrainian oncology research and care community."
  • In addition, ACS, ASCO, and Sidney Kimmel Cancer Center-Jefferson Health are engaging a network of oncologists and oncology nurses to provide support through the American Cancer Society's Clinician Volunteer Corps.

Emily Bradford Gallup is recognized by Continental Who's Who

Retrieved on: 
Friday, January 14, 2022

BOSTON, Jan. 14, 2022 /PRNewswire/ --Emily Bradford Gallup, is being recognized by Continental Who's Who as a Retired Distinguished Professional in the field of Information Systems.

Key Points: 
  • BOSTON, Jan. 14, 2022 /PRNewswire/ --Emily Bradford Gallup, is being recognized by Continental Who's Who as a Retired Distinguished Professional in the field of Information Systems.
  • Currently retired, Ms. Gallup has garnered more than 55 years of professional experience as a Systems Developer and Administrator, Consultant, and Lecturer within the information industry.
  • Among her professional experience, Ms. Gallup thrived in her previous positions before her retirement.
  • Previously, Ms. Gallup was an active member of the American Library Association and the Association of Computing Machinery.

Nektar Therapeutics Announces Data Presentations for its Immuno-Oncology Programs at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021 and the 63rd American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Tuesday, November 30, 2021

In addition, two clinical data presentations for NKTR-255 in patients with relapsed/refractory hematologic malignancies will be presented during the 63rd American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia from December 11 to December 14, 2021.

Key Points: 
  • In addition, two clinical data presentations for NKTR-255 in patients with relapsed/refractory hematologic malignancies will be presented during the 63rd American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia from December 11 to December 14, 2021.
  • ePoster will be on display on the ESMO-IO 2021 virtual meeting platform on Monday, December 6, 2021, at 12:00 pm GMT (7:00 a.m.
  • ePoster will be on display on the ASH 2021 virtual meeting platform on Sunday, December 12, 2021, at 6:00 a.m.
  • The event will follow the publication of the NKTR-214 (BEMPEG) PROPEL poster (Abstract #140P) on Monday, December 6, 2021.

Emily Bradford Gallup is recognized by Continental Who's Who

Retrieved on: 
Monday, September 13, 2021

BOSTON, Sept. 13, 2021 /PRNewswire/ -- Emily Bradford Gallup, is being recognized by Continental Who's Who as a Retired Distinguished Professional in the field of Information Systems.

Key Points: 
  • BOSTON, Sept. 13, 2021 /PRNewswire/ -- Emily Bradford Gallup, is being recognized by Continental Who's Who as a Retired Distinguished Professional in the field of Information Systems.
  • Currently retired, Ms. Gallup has garnered more than 55 years of professional experience as a Systems Developer and Administrator, Consultant, and Lecturer within the information industry.
  • Among her professional experience, Ms. Gallup thrived in her previous positions before her retirement.
  • Previously, Ms. Gallup was an active member of the American Library Association and the Association of Computing Machinery.

UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare

Retrieved on: 
Wednesday, August 4, 2021

“With Avalon GloboCare FLASH-CAR™ technology, we will use an innovative messenger ribonucleic acid (mRNA)-based technology platform that will allow researchers to create CAR cellular therapies much faster than before -- in just one to two days,” said Hsu. “We also believe this approach will reduce toxicity and overall cost associated with current CAR T-cell therapies, meaning more cancer patients could be eligible for this type of cellular therapy.”

Key Points: 
  • PITTSBURGH, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A new collaboration among UPMC Hillman Cancer Center , the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp. (NASDAQ: AVCO) aims to develop new cancer immunotherapy approaches and streamline manufacturing processes to bring these powerful treatments to cancer patients within days instead of weeks.
  • Cancer immunotherapy, which stimulates and trains a patients own immune system to target and kill tumors while leaving healthy cells intact, is an effective treatment for many cancer patients.
  • UPMC Hillman Cancer Center is the regions only National Cancer Institute-designated Comprehensive Cancer Center and is one of the largest integrated community cancer networks in the United States.
  • The more than 2,000 physicians, researchers, and staff are leaders in molecular and cellular cancer biology, cancer immunology, cancer virology, biobehavioral cancer control, and cancer epidemiology, prevention, and therapeutics.

People living with lung cancer launch a social media takeover!

Retrieved on: 
Wednesday, July 28, 2021

Los Angeles, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Join dozens of patient advocates living with lung cancer and meet the researchers working to find better treatments for the disease during a live, 4-hour social media takeover on Facebook, Twitter and Instagram on World Lung Cancer Day, August 1st.

Key Points: 
  • Los Angeles, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Join dozens of patient advocates living with lung cancer and meet the researchers working to find better treatments for the disease during a live, 4-hour social media takeover on Facebook, Twitter and Instagram on World Lung Cancer Day, August 1st.
  • However, lung cancer research is still one of the least funded cancers given that lung cancer kills more people than breast, colon and prostate cancer COMBINED.
  • The World Lung Cancer Day social media takeover is bringing patient advocates and researchers together to advocate and raise funds for increased research funding that helps people living with lung cancer do what they love to do every day.
  • LCFAs mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

Physicians’ Education Resource® Delivers Cutting-Edge Cancer Management Strategies During Two High-Impact Annual Meetings in December

Retrieved on: 
Thursday, December 10, 2020

Physicians Education Resource, LLC, (PER) is leading the industry this month with two high-impact, continuing medical educationcertified interactive annual conferences on cancer management on Saturday, Dec. 12.

Key Points: 
  • Physicians Education Resource, LLC, (PER) is leading the industry this month with two high-impact, continuing medical educationcertified interactive annual conferences on cancer management on Saturday, Dec. 12.
  • Throughout these two highly anticipated cutting-edge virtual conferences, our learners will be able to attend specific tumor type sessions and discuss cancer management strategies in real time with expert faculty.
  • These strategies can be directly applied to day-to-day management of lung cancers, melanoma, genitourinary cancers and hematologic malignancies.
  • Since 1995, PER has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases.

BriaCell Announces Collaboration with the National Cancer Institute

Retrieved on: 
Tuesday, November 10, 2020

BriaCell and National Cancer Institute to collaborate on Bria-OTS, BriaCells off-the-shelf personalized immunotherapy, as a treatment for cancer.

Key Points: 
  • BriaCell and National Cancer Institute to collaborate on Bria-OTS, BriaCells off-the-shelf personalized immunotherapy, as a treatment for cancer.
  • BERKELEY, Calif., and VANCOUVER, British Columbia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce a Cooperative Research and Development Agreement with the National Cancer Institute (NCI, Center for Cancer Research), part of the National Institutes of Health, to develop novel off-the-shelf personalized therapeutics for cancer.
  • Specifically, BriaCell and the National Cancer Institute will work together to conduct pre-clinical studies to develop and test Bria-OTS, BriaCells off-the-shelf personalized immunotherapy, as a treatment for cancer to improve upon and broaden applicability of this therapeutic approach.
  • The goal of the collaboration is to develop novel therapeutics for future clinical collaborations, allowing cancer patients to potentially benefit from potent and personalized cancer immunotherapy in the future.